My Quote Request
No products added yet
6505-01-297-0629
20 Products
VOLTAREN TABLETS
DICLOFENAC SODIUM TABLETS
NSN, MFG P/N
6505012970629
NSN
6505-01-297-0629
VOLTAREN TABLETS
DICLOFENAC SODIUM TABLETS
NSN, MFG P/N
6505012970629
NSN
6505-01-297-0629
MFG
CIBA-GEIGY CORP CIBA PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS DICLOFENAC SODIUM ACTIVE INGREDIENT
COATING FEATURE: FILM, ENTERIC
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DICLOFENAC SODIUM TABLETS 25MG 100S BT
LONG ACTION METHOD: DELAYED RELEASE
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00028-0258-01
DICLOFENAC SODIUM TABLETS
NSN, MFG P/N
6505012970629
NSN
6505-01-297-0629
NDC00028-0258-01
DICLOFENAC SODIUM TABLETS
NSN, MFG P/N
6505012970629
NSN
6505-01-297-0629
MFG
CIBA-GEIGY CORP CIBA PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS DICLOFENAC SODIUM ACTIVE INGREDIENT
COATING FEATURE: FILM, ENTERIC
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DICLOFENAC SODIUM TABLETS 25MG 100S BT
LONG ACTION METHOD: DELAYED RELEASE
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00781-1285-01
DICLOFENAC SODIUM TABLETS
NSN, MFG P/N
6505012970629
NSN
6505-01-297-0629
NDC00781-1285-01
DICLOFENAC SODIUM TABLETS
NSN, MFG P/N
6505012970629
NSN
6505-01-297-0629
MFG
SANDOZ INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS DICLOFENAC SODIUM ACTIVE INGREDIENT
COATING FEATURE: FILM, ENTERIC
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DICLOFENAC SODIUM TABLETS 25MG 100S BT
LONG ACTION METHOD: DELAYED RELEASE
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
VOLTAREN
DICLOFENAC SODIUM TABLETS
NSN, MFG P/N
6505012970629
NSN
6505-01-297-0629
MFG
CIBA-GEIGY CORP CIBA PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS DICLOFENAC SODIUM ACTIVE INGREDIENT
COATING FEATURE: FILM, ENTERIC
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DICLOFENAC SODIUM TABLETS 25MG 100S BT
LONG ACTION METHOD: DELAYED RELEASE
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00054-4222-21
DICLOFENAC SODIUM TABLETS
NSN, MFG P/N
6505012970630
NSN
6505-01-297-0630
NDC00054-4222-21
DICLOFENAC SODIUM TABLETS
NSN, MFG P/N
6505012970630
NSN
6505-01-297-0630
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MILLIGRAMS DICLOFENAC SODIUM ACTIVE INGREDIENT
COATING FEATURE: FILM, ENTERIC
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DICLOFENAC SODIUM TABLETS 75MG 60S BT
LONG ACTION METHOD: DELAYED RELEASE
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00591-0339-60
DICLOFENAC SODIUM TABLETS
NSN, MFG P/N
6505012970630
NSN
6505-01-297-0630
NDC00591-0339-60
DICLOFENAC SODIUM TABLETS
NSN, MFG P/N
6505012970630
NSN
6505-01-297-0630
MFG
DANBURY PHARMACAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MILLIGRAMS DICLOFENAC SODIUM ACTIVE INGREDIENT
COATING FEATURE: FILM, ENTERIC
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DICLOFENAC SODIUM TABLETS 75MG 60S BT
LONG ACTION METHOD: DELAYED RELEASE
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC57866-6924-02
DICLOFENAC SODIUM TABLETS
NSN, MFG P/N
6505012970630
NSN
6505-01-297-0630
NDC57866-6924-02
DICLOFENAC SODIUM TABLETS
NSN, MFG P/N
6505012970630
NSN
6505-01-297-0630
MFG
VIBRANTA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MILLIGRAMS DICLOFENAC SODIUM ACTIVE INGREDIENT
COATING FEATURE: FILM, ENTERIC
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DICLOFENAC SODIUM TABLETS 75MG 60S BT
LONG ACTION METHOD: DELAYED RELEASE
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00005-4464-38
TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLETS
NSN, MFG P/N
6505012970635
NSN
6505-01-297-0635
NDC00005-4464-38
TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLETS
NSN, MFG P/N
6505012970635
NSN
6505-01-297-0635
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT AND 37.500 MILLIGRAMS TRIAMTERENE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: W/CHILD RESISTANT CLOSURE;SCORING CHARACTERISTIC:A/A;
Related Searches:
CYTOTEC
MISOPROSTOL TABLETS
NSN, MFG P/N
6505012971448
NSN
6505-01-297-1448
MFG
SEARLE G D AND CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MICROGRAMS MISOPROSTOL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MISOPROSTOL TABLETS 200MCG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
CYTOTEC TABLETS
MISOPROSTOL TABLETS
NSN, MFG P/N
6505012971448
NSN
6505-01-297-1448
MFG
SEARLE G D AND CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MICROGRAMS MISOPROSTOL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MISOPROSTOL TABLETS 200MCG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00025-1461-31
MISOPROSTOL TABLETS
NSN, MFG P/N
6505012971448
NSN
6505-01-297-1448
MFG
CARDINAL HEALTH INC. DBA CARDINAL HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MICROGRAMS MISOPROSTOL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MISOPROSTOL TABLETS 200MCG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00005-9363-41
AMCINONIDE LOTION
NSN, MFG P/N
6505012972112
NSN
6505-01-297-2112
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE INGREDIENT AND STRENGTH: 0.100 AMCINONIDE PERCENTAGE, W/W
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMCINONIDE LOTION 60ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ADMINISTRATION:TOPICAL
Related Searches:
NDC00469-7404-60
AMCINONIDE LOTION
NSN, MFG P/N
6505012972112
NSN
6505-01-297-2112
MFG
ASTELLAS PHARMA US INC.
Description
ACTIVE INGREDIENT AND STRENGTH: 0.100 AMCINONIDE PERCENTAGE, W/W
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMCINONIDE LOTION 60ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ADMINISTRATION:TOPICAL
Related Searches:
NDC57317-0404-01
AMCINONIDE LOTION
NSN, MFG P/N
6505012972112
NSN
6505-01-297-2112
MFG
ASTELLAS PHARMA US INC.
Description
ACTIVE INGREDIENT AND STRENGTH: 0.100 AMCINONIDE PERCENTAGE, W/W
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMCINONIDE LOTION 60ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ADMINISTRATION:TOPICAL
Related Searches:
NDC57317-0404-60
AMCINONIDE LOTION
NSN, MFG P/N
6505012972112
NSN
6505-01-297-2112
MFG
ASTELLAS PHARMA US INC.
Description
ACTIVE INGREDIENT AND STRENGTH: 0.100 AMCINONIDE PERCENTAGE, W/W
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMCINONIDE LOTION 60ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ADMINISTRATION:TOPICAL
Related Searches:
01-11892
CHLORZOXAZONE TABLETS,USP
NSN, MFG P/N
6505012973819
NSN
6505-01-297-3819
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CHLORZOXAZONE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00093-0542-05
CHLORZOXAZONE TABLETS,USP
NSN, MFG P/N
6505012973819
NSN
6505-01-297-3819
NDC00093-0542-05
CHLORZOXAZONE TABLETS,USP
NSN, MFG P/N
6505012973819
NSN
6505-01-297-3819
MFG
LEMMON CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CHLORZOXAZONE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00182-1189-05
CHLORZOXAZONE TABLETS,USP
NSN, MFG P/N
6505012973819
NSN
6505-01-297-3819
NDC00182-1189-05
CHLORZOXAZONE TABLETS,USP
NSN, MFG P/N
6505012973819
NSN
6505-01-297-3819
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CHLORZOXAZONE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC23513-0660-01
CAPSAICIN CREAM
NSN, MFG P/N
6505012974289
NSN
6505-01-297-4289
MFG
REESE PHARMACEUTICAL CO NAPA AUTO PARTS OWEL SERVICE ALASKA DIV
Description
ACTIVE INGREDIENT AND STRENGTH: 0.025 CAPSAICIN PERCENTAGE, W/W
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CAPSAICIN CREAM 0.025% 45GM TUBE 12S PG
PRIMARY CONTAINER CONTENT QUANTITY: 45.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00034-0522-03
MORPHINE SULFATE ORAL SOLUTION
NSN, MFG P/N
6505012978130
NSN
6505-01-297-8130
NDC00034-0522-03
MORPHINE SULFATE ORAL SOLUTION
NSN, MFG P/N
6505012978130
NSN
6505-01-297-8130
MFG
THE FREDERICK PURDUE COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS MORPHINE SULFATE PER 5 MILLILITERS
ADMINISTRATION: ORAL
FLAVOR: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DISPENSER TOP
SPECIAL FEATURES: METER DOSE DISPENSER BOTTLE
